Employers may not cover GLP-1 drugs due to high cost

(CNN)– More and more people are using weight-loss drugs, and it’s costing employers big time.

According to a new study of employer health benefits so many people are using expensive GLP-1 medications, some companies are reconsidering whether they should cover the cost.

The number of larger companies covering obesity drugs soared to 43% this year which is up from 28% last year.

Among smaller firms with less than a thousand workers about 16% provide coverage for obesity drugs.